RecruitingNot ApplicableNCT06556693

Janus II Feasibility

Janus II: A Feasibility Study to Evaluate Response to Remede Dual Channel System Therapy


Sponsor

Zoll Medical Corporation

Enrollment

40 participants

Start Date

Aug 12, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The objectives of this study are to evaluate the feasibility of the remedē® Dual Channel System at implant and overnight sleep studies and to assess chronic safety.


Eligibility

Min Age: 22 Years

Inclusion Criteria3

  • Severe sleep disordered breathing
  • Expected to tolerate study procedures
  • No heart failure or medically stable heart failure

Exclusion Criteria14

  • Currently implanted with a neurostimulator to treat sleep disordered breathing without sponsor approval
  • History of severe COPD or pulmonary arterial hypertension
  • Current or previous history of nerve injury or palsy
  • Prior cervical surgeries or radiation treatment to head region
  • Known need for an MRI
  • History of psychosis or severe bipolar disorder
  • Active Infection or sepsis within 30 days of enrollment
  • Currently on kidney dialysis or significantly reduced kidney function
  • Hemoglobin less than 8g/dl
  • Pacemaker dependance
  • New defibrillator or any implantable device or device generator changeout within 30 days prior to study implant or anticipated within the first 12 months
  • Other conditions or anticipated surgical procedure expected to affect ability to complete study procedures
  • Allergy to contrast dye unless can be prophylactically treated
  • Known pregnancy or planning to become pregnant

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDual Channel Stimulation

implant of dual channel stimulation device


Locations(3)

The Insomnia and Sleep Institute of Arizona LLC

Scottsdale, Arizona, United States

The University of Michigan Health-West

Wyoming, Michigan, United States

The Ohio State University

Columbus, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06556693


Related Trials